We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

12 hedge funds and large institutions have $480K invested in Bionano Genomics in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

33% more funds holding

Funds holding: 9 → 12 (+3)

1.49% less ownership

Funds ownership: 4.3% → 2.81% (-1.5%)

76% less capital invested

Capital invested by funds: $2.01M → $480K (-$1.53M)

Holders
12
Holders Change
+3
Holders Change %
+33.33%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$190K
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$44K
3
UBS Group
UBS Group
Switzerland
+$39K
4
BlackRock
BlackRock
New York
+$18.6K
5
Northern Trust
Northern Trust
Illinois
+$10.7K

Top Sellers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
-$1.5M
2
Two Sigma Investments
Two Sigma Investments
New York
-$71K
3
TSS
Two Sigma Securities
New York
-$14K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$5.08K

BNGO Hedge Fund Activity: Q1 2020 in Review

12 of the 4,548 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q1 2020, worth a combined $480K — down 76% from $2.01M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new BNGO positions and 3 closed out — a net gain of 4 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $190K. The largest seller was Sio Capital Management, exiting entirely with an estimated $1.5M sold.

  • 12 institutional investors held Bionano Genomics (BNGO) as of Q1 2020, up from 9 in Q4 2019.
  • Funds reported $480K of Bionano Genomics stock for Q1 2020, down 76% quarter-over-quarter.
  • 7 funds opened new Bionano Genomics positions in Q1 2020 and 3 closed out, a net change of +4 holders.
  • The largest Bionano Genomics buyer in Q1 2020 was Vanguard Group, an estimated $190K added.
  • The largest Bionano Genomics seller in Q1 2020 was Sio Capital Management, an estimated $1.5M sold.

Based on aggregated 13F filings for Q1 2020.